Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease

By  

Digestion, Vol. 85, Iss. 1, 2011-12 ,pp. : 47-54

Karger

Access to resources Recommend Favorite

Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life

By Befrits Ragnar   Wikman Ola   Blomquist Lars   Hjortswang Henrik   Hammarlund Per   Bajor Antal   Klintman Daniel   Blom Håkan  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 9, 2013-09 ,pp. : 1027-1032

Informa Healthcare

Access to resources Recommend Favorite

Intravenous Iron Replacement Improves Quality of Life in Hypoferritinemic Inflammatory Bowel Disease Patients with and without Anemia

By  

Digestive Diseases, Vol. 35, Iss. 5, 2017-03 ,pp. : 444-448

Karger

Access to resources Recommend Favorite

High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: A longitudinal 2-year follow-up study

By Bager Palle   Befrits Ragnar   Wikman Ola   Lindgren Stefan   Moum Bjørn   Hjortswang Henrik   Dahlerup Jens F.  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 11, 2013-11 ,pp. : 1286-1293

Informa Healthcare

Access to resources Recommend Favorite

Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

By Erichsen Kari   Ulvik Rune   Nysaeter Gunnar   Johansen Jack   Ostborg Jens   Berstad Arnold   Berge Rolf   Hausken Trygve  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 9, 2005-09 ,pp. : 1058-1065

Informa Healthcare

Access to resources Recommend Favorite